Bills · S 2761
IN COMMITTEE· 119TH CONGRESS
Senate BillS 2761Health
RESULTS Act
INTRO SEP 10· LAST ACTION SEP 10
READING
17MIN
COSPONSORS
13BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenVoters should care about this bill because it impacts the cost and availability of common medical lab tests for millions of Medicare beneficiaries. The current method for setting Medicare payment rates for lab tests, which relies on labs self-reporting private rates, has been a source of debate, with concerns about accuracy and the administrative burden on labs.
If this bill becomes law, Medicare payments for many lab tests would be based on a more comprehensive and independently collected dataset of private market prices. This could lead to more stable and accurate reimbursement rates, which ideally helps ensure labs can continue providing services without facing unsustainable payment cuts or receiving excessive payments. If it doesn't become law, the current system of individual lab reporting for private payor rates would continue, along with ongoing debates about its effectiveness and fairness in setting Medicare prices.
KEY PROVISIONS
4AI-extractedPROVISION 01
Medicare will acquire data for widely available non-advanced diagnostic laboratory tests from a qualifying independent claims data entity, rather than individual labs, starting January 1, 2028.
This aims to create a more accurate and representative basis for Medicare payment rates for common lab tests by using a broader dataset from many private insurers.
PROVISION 02
The bill defines strict criteria for a "qualifying independent claims data entity," requiring it to be a national non-profit, independent from healthcare providers or insurers, maintain a large and representative database of private payor claims, and adhere to privacy and quality standards.
This provision ensures that the new data source for Medicare payment rates is reliable, unbiased, and comprehensive.
PROVISION 03
Existing data reporting deadlines for laboratories are shifted by two years, for example, from January 1, 2025, to January 1, 2027, for some requirements, and the reporting frequency changes from every three years to every four years.
This allows for a transition period for labs and the government to adapt to the new data collection system before it fully takes effect.
PROVISION 04
The definition of an "applicable laboratory" (which labs are subject to reporting requirements) is updated for reporting periods beginning in 2028 and subsequent years, referencing existing regulations but with specific exclusions.
This clarifies which laboratories will be directly affected by the data collection changes and which might be exempt from certain direct reporting duties.
SPONSORSHIP
1 + 13
R· North Carolina
YRS IN OFFICE
11
BILLS LED
58
COSPONSOR BREAKDOWNBIPARTISAN · 92%
DEM 6 REP 7 IND 0
ACTION TIMELINE
2 EVENTSSEP 10
Introduced in Senate
SEP 10
Read twice and referred to the Committee on Finance.
BILL INFO
TypeSenate Bill
NumberS 2761
Congress119th
StatusIn Committee
IntroducedSep 10, 2025
Last actionSep 10, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · FINANCE COMMITTEE · INTRODUCED SEP 10, 2025
Senate BillS 2761Health
RESULTS Act
INTRODUCED SEP 10, 2025· LAST ACTION SEP 10, 2025
PASSAGE CHANCES
—%
READING
17 min
COSPONSORS
13
COMPLEXITY
Moderate
